Consultant - Immunology and animal model research

  • Added Date: Thursday, 16 January 2025
  • Deadline Date: Friday, 31 January 2025
5 Steps to get a job in the United Nations

..

Qualifications

Purpose of consultancy

Contribute to developing medical countermeasures under the R&D Blueprint for Epidemics.

Background

The R&D Blueprint for epidemics is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics. Its aim is to fast-track the availability of effective tests, vaccines and medicines that can be used to save lives and avert large scale crises.
Information on the activities can be found hereย Blueprint (who.int).

At the core of its efforts lies the concept of 'Pathogen Prioritization' to target medical countermeasure research on pathogens that have the greatest risk of causing a future epidemic, pandemic or PHEIC. In November 2022, the WHO launched a new global Pathogen Prioritization effort that involved over 200 scientists from more than 50 countries who reviewed evidence across 28 virus families and one core group of bacteria, totalling 1,652 pathogens. On 9-10 May 2024, a Pathogen Prioritization meeting was organized served as the culmination of the process and provided an opportunity to finalize the prioritization results and develop a strategy for the future. The new strategy was presented at the Global Pandemic Preparedness Summit 2024 in Rio de Janeiro (Report) (Press Release). It advocates a broad-based approach, emphasizing research across all pathogen families, regardless of their current pandemic potential. This comprehensive strategy aims to reduce the risk of overlooking emerging pathogens that may evade existing surveillance systems. By prioritizing research at the family level rather than focusing on individual pathogens, we are better equipped to respond to unforeseen variants, zoonotic transmissions, and unknown threats, ensuring that research efforts are more agile and comprehensive.

To implement this new scientific framework, WHO is partnering with global research institutions to establish CORCs for each pathogen family. Each consortium will be anchored by a WHO Collaborating Centre that will serve as the research hub. CORCs will include researchers, developers, funders, regulators, and trial experts to foster collaboration and promote equitable participationโ€”especially from regions where these pathogens are known or likely to circulate. This decentralized structure ensures representation from high-, middle-, and low-income countries, enhancing the global response to emerging health threats.

Deliverables

This vacancy is archived.

Recommended for you